Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enteric coated levo-dopa in clinical practice.

E P Hicks, M W O'Halloran

    Proceedings of the Australian Association of Neurologists
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of the plasma free thyroxine level as a test of thyroid function.

    British medical journal·2010
    Same author

    The Relation of Rat-fleas to Plague in Shanghai.

    The Journal of hygiene·2010
    Same author

    The Value of Methods for the Differentiation of Bacilli of the Coli-aerogenes Group, when applied in Shanghai.

    The Journal of hygiene·2010
    Same author

    Notes on Organisms Serologically Related to S. enteritidis Gärtner: II. Observations on S. paratyphus N 2 (Salmonella, Type Moscow): an Organism complicating Relapsing Fever.

    The Journal of hygiene·2010
    Same author

    Early orthodontic treatment: what are the imperatives?

    Journal of the American Dental Association (1939)·2000
    Same author

    Third molar management: a case against routine removal in adolescent and young adult orthodontic patients.

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·1999
    Same journal

    On the visual disturbances associated with massive basal aneurysms.

    Proceedings of the Australian Association of Neurologists·1976
    Same journal

    The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.

    Proceedings of the Australian Association of Neurologists·1976
    Same journal

    An animal model for the study of drugs in the central nervous system.

    Proceedings of the Australian Association of Neurologists·1976
    Same journal

    Some aspects of tuberculous meningitis in Surabaya.

    Proceedings of the Australian Association of Neurologists·1976
    Same journal

    Pattern visual evoked potentials in the diagnosis of multiple sclerosis and other disorders.

    Proceedings of the Australian Association of Neurologists·1976
    Same journal

    Epilepsy and driving.

    Proceedings of the Australian Association of Neurologists·1976
    See all related articles

    Enteric-coated Levo-dopa significantly improved Parkinsonism symptoms in 84% of patients, including those intolerant to standard Levo-dopa. This new formulation requires a lower stabilization dose and may control "on-off" phenomena.

    Area of Science:

    • Neurology
    • Clinical Pharmacology

    Background:

    • Parkinsonism is a debilitating neurological disorder.
    • Standard Levo-dopa therapy can cause intolerance and
    • on-off
    • phenomena.

    Purpose of the Study:

    • To evaluate the efficacy and safety of enteric-coated Levo-dopa in Parkinsonism patients.
    • To compare the therapeutic outcomes with standard Levo-dopa.

    Main Methods:

    • A clinical trial involving nineteen Parkinsonism patients.
    • Twelve patients were intolerant to standard Levo-dopa; seven were new Levo-dopa users.
    • Treatment duration ranged from three to twelve months.

    Main Results:

    • 84% of all patients showed improvement.

    Related Experiment Videos

  • 58% of poor responders to standard Levo-dopa improved markedly.
  • The mean stabilization dose for enteric-coated Levo-dopa was 1.5g daily, significantly lower than standard Levo-dopa (3.0g).
  • 60% of patients experienced no side-effects; 20% had mild or transient side-effects.
  • The enteric-coated preparation controlled "on-off" phenomena in at least 50% of affected cases.

    • Conclusions:

    • Enteric-coated Levo-dopa is effective and well-tolerated, offering a viable alternative for Parkinsonism patients.
    • It demonstrates a significantly lower required stabilization dose and improved management of motor fluctuations.
    • Recommended for routine outpatient use, with caution regarding vitamin tonic interactions.